Patents Assigned to PROTAMED, INC.
  • Compounds and compositions for use a modulators of tau aggregation and alleviation of tauopathies
    Patent number: 9469605
    Abstract: This invention relates to the use of bis- and tris-dihydroxyaryl compounds as well as sulfonamides, heteroaryls, tricycloalkyl and their analogs and pharmaceutically acceptable salts, for modulating tau aggregation and alleviating tauopathies, such as Alzheimer's disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and familial frontotemporal dementia/Parkinsonism linked to chromosome 17 (FTDP-17), amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: October 18, 2016
    Assignee: PROTAMED, INC.
    Inventors: Alan D Snow, Qubai Hu, Thomas Lake, Judy Cam
  • Compounds for the treatment of neurodegenerative diseases
    Patent number: 9334251
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: May 10, 2016
    Assignee: PROTAMED, INC.
    Inventors: Luke A Esposito, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D Snow